Luye Pharma Group, a China-based pharmaceutical company, has signed a new partnership agreement with Distribution Solutions Phils Inc (Distriphil), a Philippines-based pharmaceutical distribution company, it was reported on Thursday.
According to the terms of the collaboration, Luye Pharma has granted the exclusive Phillippines distribution and marketing rights to Distriphil for the central nervous system drugs Seroquel and Seroquel XR.
Both products are atypical anti-psychotic medicines with antidepressant properties. Seroquel in mainly intended to treat schizophrenia and bipolar disorder while Seroquel XR is also approved in certain markets for major depressive disorder and generalised anxiety disorder.
Nuvalent commences NVL-655 phase 2 clinical trial in subjects with NSCLC and other solid tumours
GC Biopharma's GC1130A receives EMA Orphan Drug Designation
Guangzhou Fermion Technology's FZ008-145 IND application receives Chinese regulatory approval
Newron enrols 290 patients in schizophrenia study
Vistagen granted European patent for AV-101 to treat neuropathic pain
GenSight Biologics reports business and financial update
Alora Pharmaceuticals announces Relexxii commercial launch
IGC Pharma granted patent for Alzheimer's drug formulation
NRx Pharmaceuticals signs data agreement with Columbia University for IV Ketamine trials